If you’re like me, you can really only take so much of the daily commentary on any news media outlet that is entirely and completely fixed on COVID-19. That isn’t to minimize the importance of the crisis-level measures that, I think are appropriately being taken on a national scale to try to slow the spread […]
Read MoreAt the beginning of my career in the financial industry, I was a licensed rep for one of the largest mutual fund and discount brokerage companies in North America. Looking over the mutual funds that we offered, and digging into their respective investment philosophies was something I found to be really fascinating. It wasn’t just […]
Read MoreI often observe, and write about the need to try to filter through the “noise” of the market to find the right ways and places to put your money to work for you. A lot of that noise, of course comes from media outlets, including market news. The irony of my observation is that it […]
Read MoreI had to chuckle this weekend a bit as I read some some market news reports. The market has dropped far enough that in the latter part of the week, I think investors were starting to look for reasons to start buying. Friday looked set to mark the first time in weeks the market managed […]
Read MoreInstead of following my normal routine, which is to highlight a specific stock, I think today it’s probably a good idea to pull the lens back and take a look at the broader market. It’s practically impossible to ignore the fact that the market dropped into bear market territory last week. Fear and, yes, even […]
Read MoreNo. 6: Satsuma Pharmaceuticals Inc. (STSA) Satsuma is a San Francisco-based pharmaceutical firm developing a dry-powder nasal spray to treat migraines. The product candidate — STS101 — can be quickly self-administered with a proprietary pre-filled, single-use, nasal delivery device. The company began a Phase 3 electronic medical records and genomics (eMERGE) trial for STS101 this […]
Read MoreHurricane Dorian just barreled its way through the Bahamas earlier this week, and estimates of the damage have already skyrocketed to dramatic levels. A new Bloomberg report cited risk modeler and insurance firm Karen Clark & Co., which said that damage to commercial, residential, and industrial properties as well as business-interruption expenses could total $7 […]
Read MoreNo. 5: Concho Resources Inc. (CXO) Shares of energy producer Concho Resources — which exclusively operates in the Permian Basin considered the largest oilfield in the U.S. — climbed 5.08% during Wednesday’s session, going from $69.44 to $72.97. Despite WTI oil prices being up more than 17% in 2019, CXO stock is in the red […]
Read MoreAlexion Pharmaceuticals Inc. (ALXN) has had an abysmal run over just the last two sessions. While Friday saw the biotech — known for developing Soliris, a treatment for atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH) — become the S&P 500’s second-worst performer that session, the stock outdid itself during Tuesday’s session by […]
Read MoreNo. 5: Wynn Resorts Ltd. (WYNN) Shares of Wynn Resorts — the giant casino operator that flung into the spotlight in February 2018 after former CEO Steve Wynn resigned amid sexual misconduct allegations — vaulted 3.6% during Friday’s session from $106.32 to a more than one-week high of $110.15. The stock has whipsawed all over […]
Read MoreFive oil stocks made up the S&P’s top 10 biggest gainers during Wednesday’s session as investors celebrated a better-than-expected weekly report from the U.S. Energy Information Administration (EIA). Shares of the companies soared alongside West Texas Intermediate (WTI) oil prices, which leaped to their best close in more than a week. While market participants typically […]
Read MoreShares of Altria Group Inc. (MO) and Philip Morris International Inc. (PM) — both of which own Marlboro cigarettes, with the former selling them in the U.S. and the latter selling them internationally — logged sizable losses during Tuesday’s session after the firms announced a potential plan to mitigate falling cigarette sales. Philip Morris — […]
Read MoreJohnson & Johnson (JNJ) On Monday, an Oklahoma judge ruled against the pharma and consumer goods giant in the state’s highly publicized opioid case. The ruling marks the first major opioid crisis-related U.S. penalty against a major drug producer and will force the firm to pay a fine of $572 million, only about 1% of […]
Read MoreNo. 5: Hormel Foods Corp. (HRL) A theme that runs through this list is post-earnings pops, which Hormel — the food processing giant known for producing packaged meats like Spam — certainly saw during Thursday’s session. Shares of HRL gained 4.8% from $40.97 to $42.95, the best close since April 2 when they ended the […]
Read More